Literature DB >> 16739336

HPV16 DNA in histologically confirmed tumour-free neck lymph nodes of head and neck cancers.

Markus Hoffmann1, Antje Orlamünder, Jan Sucher, Stefan Gottschlich, Tibor Görögh, Asita Fazel, Petra Ambrosch, Werner Rittgen, Elisabeth Schwarz, Tomas Kahn.   

Abstract

BACKGROUND: Human papillomavirus (HPV) has been demonstrated in lymph node neck metastases (NM) of HPV-positive squamous cell carcinomas of the head and neck (HNSCC), underscoring the possible role of HPV for HNSCC progression. Reports on HPV infections in histopathologically tumour-free lymph-nodes of the SCC of the uterine cervix developing higher rates of lymph-node metastases and recurrences later in the survey of the patients was the starting point of the present study.
MATERIALS AND METHODS: The presence of HPV-DNA in primary tumours (PT, n=45), NM (n=45) and histologically confirmed tumour-free neck lymph-nodes (LN, n=102) of HNSCC from 60 patients was analysed by PCR and Southern blot hybridisation.
RESULTS: A highly positive correlation of simultaneous HPV-DNA detection in PT and NM was demonstrated. In the case of HPV-positivity of PT and/or NM [24/60 cases (40%)], 11/24 (45.8%) LN contained HPV-DNA, as well. Accepting HPV demonstration as a marker for the presence of micro-metastasis, HPV analysis would result in an upstaging of the N category in 4 out of these 11 patients.
CONCLUSION: Considering the high agreement of HPV-DNA detection in PT and simultaneous HPV-DNA demonstration in the draining NM corroborating the monoclonal character of the tumour cells, the HPV-DNA presence in LN seems to be indicative of micro-metastasis in these lymph nodes. Thus, HPV analysis might be another powerful tool for the definition of the N-status of HPV-positive HNSCC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16739336

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma.

Authors:  Alice Y Chuang; Tony C Chuang; Steven Chang; Shaoyu Zhou; Shahnaz Begum; William H Westra; Patrick K Ha; Wayne M Koch; Joseph A Califano
Journal:  Oral Oncol       Date:  2008-03-07       Impact factor: 5.337

2.  Human papillomavirus in head and neck squamous cell carcinoma of unknown primary is a common event and a strong predictor of survival.

Authors:  David Hebbelstrup Jensen; Nora Hedback; Lena Specht; Estrid Høgdall; Elo Andersen; Marianne Hamilton Therkildsen; Lennart Friis-Hansen; Bodil Norrild; Christian von Buchwald
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

3.  HPV and Oropharyngeal Cancer in the Eighth Edition of the TNM Classification: Pitfalls in Practice.

Authors:  Markus Hoffmann; Silke Tribius
Journal:  Transl Oncol       Date:  2019-06-06       Impact factor: 4.243

Review 4.  Relevance of Human Papillomaviruses in Head and Neck Cancer-What Remains in 2021 from a Clinician's Point of View?

Authors:  Markus Hoffmann; Elgar Susanne Quabius
Journal:  Viruses       Date:  2021-06-18       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.